Validity of Pharmacoepidemiologic Drug and Diagnosis Data

Pharmacoepidemiology, Fourth Edition

Volumn , Issue , 2007, Pages 709-765

  Strom, Brian L ^a,b,c   West, Suzanne L ^d   Poole, Charles ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d IL   (United States)

Author keywords

Correcting measures of association; Group Health Cooperative (GHC); HIPAA Privacy Rule; Measurement error influence; Measurement error quantitative indices; Medication use in pregnancy; Nondifferential misclassification of exposure; Nonhormonal medication use; Pharmacoepidemiologic drug and diagnosis data; UK General Practice Research Database

Indexed keywords

EID: 84889313890     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470059876.ch45     Document Type: Chapter

References (226)

1. Gordis L. Assuring the quality of questionnaire data in epidemiologic research. Am J Epidemiol 1979;109:21-4.
2. Keeble W, Cobbe SM. Patient recall of medication details in the outpatient clinic. Audit and assessment of the value of printed instructions requesting patients to bring medications to clinic. Postgrad Med J 2002;78:479-82.
3. Brody DS. An analysis of patient recall of their therapeutic regimens. J Chronic Dis 1980;33:57-63.
4. Warnecke RB, Sudman S, Johnson TP, O'Rourke D, Davis AM, Jobe JB. Cognitive aspects of recalling and reporting healthrelated events: Papanicolaou smears, clinical breast examinations, and mammograms. Am J Epidemiol 1997;146:982-92.
5. Tourangeau R. Cognitive sciences and survey methods. In: Janine TB, Straf ML, Tanur JM, Tourangeau R, eds, Cognitive Aspects of Survey Methodology: Building a Bridge between Disciplines. Washington, DC: National Academy Press, 1984; pp. 73-100.
6. Willis GB, Royston P, Bercini D. The use of verbal report methods in the development and testing of survey questionnaires. Appl Cognit Psychol 1991;5:251-67.
7. Tourangeau R, Rips LJ, Rasinski K. The Psychology of Survey Response. Cambridge, MA: Cambridge University Press, 2000.
8. Wheeler MA, Stuss DT, Tulving E. Toward a theory of episodic memory: the frontal lobes and autonoetic consciousness. Psychol Bull 1997;121:331-54.
9. Belli RF. The structure of autobiographical memory and the event history calendar: potential improvements in the quality of retrospective reports in surveys. Memory 1998;6:383-406.
10. Conway MA. Sensory-perceptual episodic memory and its context: autobiographical memory. Philos Trans R Soc Lond B Biol Sci 2001;356:1375-84.
11. Tulving E. Episodic memory: from mind to brain. Annu Rev Psychol 2002;53:1-25.
12. Allen PA, Sliwinski M, Bowie T. Differential age effects in semantic and episodic memory, Part II: Slope and intercept analyses. Exp Aging Res 2002;28:111-42.
13. Allen PA, Sliwinski M, Bowie T, Madden DJ. Differential age effects in semantic and episodic memory. J Gerontol B Psychol Sci Soc Sci 2002;57:173-86.
14. Kelsey JL, Thompson WD, Evans AS. Methods in observational epidemiology. In: Monographs in Epidemiology and Biostatistics, vol. 10. New York: Oxford University Press, 1986.
15. Sackett DL. Bias in analytic research. J Chronic Dis 1979;32:51-63.
16. Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 1986;123:670-6.
17. Chavance M, Dellatolas G, Lellouch J. Correlated nondifferential misclassifications of disease and exposure: application to a cross-sectional study of the relation between handedness and immune disorders. Int J Epidemiol 1992;21:537-46.
18. Kristensen P. Bias from nondifferential but dependent misclassification of exposure and outcome. Epidemiology 1992;3:210-15.
19. Dosemeci M, Wacholder S, Lubin JH. Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol 1990;132:746-8.
20. Rothman KJ, Greenland S. Precision and validity in epidemiologic studies. In: Modern Epidemiology, 2nd edn. Philadelphia, PA: Lippincott, Williams & Wilkins, 1998; pp. 129-30.
21. Poole C. Exceptions to the rule about nondifferential misclassification. Am J Epidemiol 1985;122:508.
22. Rodgers A, MacMahon S. Systematic underestimation of treatment effects as a result of diagnostic test inaccuracy: implications for the interpretation and design of thromboprophylaxis trials. Thromb Haemost 1995;73:167-71.
23. Thomas DC. Re: "When will nondifferential misclassification of an exposure preserve the direction of a trend?". Am J Epidemiol 1995;142:782-4.
24. Weinberg CR, Umbach DM, Greenland S. Weinberg et al. Reply-Re: "When will nondifferential misclassification of an exposure preserve the direction of a trend?". Am J Epidemiol 1995;142:784.
25. Wacholder S, Armstrong B, Hartge P. Validation studies using an alloyed gold standard. Am J Epidemiol 1993;137:1251-8.
26. Rothman KJ, Greenland S. Basic methods for sensitivity analysis and external adjustment. In: Modern Epidemiology, 2nd edn. Philadelphia, PA: Lippincott, Williams & Wilkins, 1998; pp. 343-57.
27. Maclure M, Willett WC. Misinterpretation and misuse of the κ statistic. Am J Epidemiol 1987;126:161-9.
28. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
29. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
30. Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol 1977;105:488-95.
31. Greenland S, Kleinbaum DG. Correcting for misclassification in two-way tables and matched-pair studies. Int J Epidemiol 1983;12:93-7.
32. Willett W. An overview of issues related to the correction of non-differential exposure measurement error in epidemiologic studies. Stat Med 1989;8:1031-40.
33. Raphael K. Recall bias: a proposal for assessment and control. Int J Epidemiol 1987;16:167-70.
34. Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol 1996;25:1107-16.
35. Lash TL, Fink AK. Semi-automated sensitivity analysis to assess systematic errors in observational data. Epidemiology 2003;14:451-8.
36. Horwitz RI, Feinstein AR. Alternative analytic methods for case-control studies of estrogens and endometrial cancer. N Engl J Med 1978;299:1089-94.
37. Hutchison GB, Rothman KJ. Correcting a bias? N Engl J Med 1978;299:1129-30.
38. Greenland S. A mathematic analysis of the "epidemiologic necropsy." Ann Epidemiol 1991;1:551-8.
39. Greenland S. Sensitivity analysis, Monte Carlo risk analysis, and Bayesian uncertainty assessment. Risk Anal 2001;21:579-83.
40. Phillips CV. Quantifying and reporting uncertainty from systematic errors. Epidemiology 2003;14:459-66.
41. Phillips CV, LaPole LM. Quantifying errors without random sampling. BMC Med Res Methodol 2003;3:9.
42. Greenland S. The impact of prior distributions for uncontrolled confounding and response bias: a case study of the relation of wire codes and magnetic fields to childhood leukemia. J Am Stat Assoc 2003;98:47-54.
43. Steenland K, Greenland S. Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer. Am J Epidemiol 2004;160:384-92.
44. Kirking DM, Ammann MA, Harrington CA. Comparison of medical records and prescription claims files in documenting prescription medication therapy. J Pharmacoepidemiol 1996;5:3-15.
45. Monson RA, Bond CA. The accuracy of the medical record as an index of outpatient drug therapy. JAMA 1978;240:2182-4.
46. West SL, Strom BL, Freundlich B, Normand E, Koch G, Savitz DA. Completeness of prescription recording in outpatient medical records from a health maintenance organization. J Clin Epidemiol 1994;47:165-71.
47. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP. Comparison of prescription and medical records in reflecting patient antihypertensive drug therapy. Ann Pharmacother 1994;28:99-104.
48. Buchsbaum DG, Boling P, Groh M. Residents' underdocumentation in elderly patients' records of prescriptions for benzodiazepine. J Med Educ 1987;62:438-40.
49. Lau HS, Florax C, Porsius AJ, De Boer A. The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol 2000;49:597-603.
50. Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder ES, Stolley PD et al. Using a claims database to investigate drug-induced Stevens-Johnson syndrome. Stat Med 1991;10:565-76.
51. Guess HA, West R, Strand LM, Helston D, Lydick EG, Bergman U et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal antiinflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol 1988;41:35-45.
52. Lloyd SS, Rissing JP. Physician and coding errors in patient records. JAMA 1985;254:1330-6.
53. Klemetti A, Saxen L. Prospective versus retrospective approach in the search for environmental causes of malformations. Am J Public Health Nations Health 1967;57:2071-5.
54. Bean JA, Leeper JD, Wallace RB, Sherman BM, Jagger H. Variations in the reporting of menstrual histories. Am J Epidemiol 1979;109:181-5.
55. Coulter A, McPherson K, Elliott S, Whiting B. Accuracy of recall of surgical histories: a comparison of postal survey data and general practice records. Community Med 1985;7:186-9.
56. Adam SA, Sheaves JK, Wright NH, Mosser G, Harris RW, Vessey MP. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer 1981;44:45-50.
57. Glass R, Johnson B, Vessey M. Accuracy of recall of histories of oral contraceptive use. Br J Prev Soc Med 1974;28:273-5.
58. Nischan P, Ebeling K, Thomas DB, Hirsch U. Comparison of recalled and validated oral contraceptive histories. Am J Epidemiol 1993;138:697-703.
59. Rosenberg MJ, Layde PM, Ory HW, Strauss LT, Rooks JB, Rubin GL. Agreement between women's histories of oral contraceptive use and physician records. Int J Epidemiol 1983;12:84-7.
60. Stolley PD, Tonascia JA, Sartwell PE, Tockman MS, Tonascia S, Rutledge A et al. Agreement rates between oral contraceptive users and prescribers in relation to drug use histories. Am J Epidemiol 1978;107:226-35.
61. Persson I, Bergkvist L, Adami HO. Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms. Int J Epidemiol 1987;16:222-8.
62. Goodman MT, Nomura AM, Wilkens LR, Kolonel LN. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 1990;131:815-25.
63. Horwitz RI, Feinstein AR, Stremlau JR. Alternative data sources and discrepant results in case-control studies of estrogens and endometrial cancer. Am J Epidemiol 1980;111:389-94.
64. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982;116:114-22.
65. Spengler RF, Clarke EA, Woolever CA, Newman AM, Osborn RW. Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases. Am J Epidemiol 1981;114:497-506.
66. Coulter A, Vessey M, McPherson K, Crossley B. The ability of women to recall their oral contraceptive histories. Contraception 1986;33:127-37.
67. Van den Brandt PA, Petri H, Dorant E, Goldbohm RA, Van de Crommert S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci 1991;13:91-6.
68. West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995;142:1103-12.
69. Strom BL, Schinnar R. An interview strategy was critical for obtaining valid information on the use of hormone replacement therapy. J Clin Epidemiol. 2004;57:1210-13.
70. Klungel OH, de Boer A, Paes AH, Herings RM, Seidell JC, Bakker A. Influence of question structure on the recall of selfreported drug use. J Clin Epidemiol 2000;53:273-7.
71. Hulka BS, Kupper LL, Cassel JC, Efird RL. Medication use and misuse: physician-patient discrepancies. J Chronic Dis 1975;28:7-21.
72. Landry JA, Smyer MA, Tubman JG, Lago DJ, Roberts J, Simonson W. Validation of two methods of data collection of self-reported medicine use among the elderly. Gerontologist 1988;28:672-6.
73. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J Am Geriatr Soc 1991;39:1079-84.
74. Kehoe R, Wu SY, Leske MC, Chylack LT. Comparing self-reported and physician-reported medical history. Am J Epidemiol 1994;139:813-18.
75. Sandvik H, Hunskaar S. General practitioners' management of female urinary incontinence. Medical records do not reflect patients' recall. Scand J Prim Health Care 1995;13:168-74.
76. Law MG, Hurley SF, Carlin JB, Chondros P, Gardiner S, Kaldor JM. A comparison of patient interview data with pharmacy and medical records for patients with acquired immunodeficiency syndrome or human immunodeficiency virus infection. J Clin Epidemiol 1996;49:997-1002.
77. Cotterchio M, Kreiger N, Darlington G, Steingart A. Comparison of self-reported and physician-reported antidepressant medication use. Ann Epidemiol 1999;9:283-9.
78. Smith NL, Psaty BM, Heckbert SR, Tracy RP, Cornell ES. The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. J Clin Epidemiol 1999;52:143-6.
79. Clegg LX, Potosky AL, Harlan LC, Hankey BF, Hoffman RM, Stanford JL et al. Comparison of self-reported initial treatment with medical records: results from the prostate cancer outcomes study. Am J Epidemiol 2001;154:582-87.
80. Mackenzie SG, Lippman A. An investigation of report bias in a case-control study of pregnancy outcome. Am J Epidemiol 1989;129:65-75.
81. Feldman Y, Koren G, Mattice K, Shear H, Pellegrini E, MacLeod SM. Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy. Teratology 1989;40:37-45.
82. de Jong PCMP, Berns MPH, van Duynhoven YTHP, Nijdam WS, Eskes TKAB, Zielhuis GA. Recall of medication during pregnancy: validity and accuracy of an adjusted questionnaire. Pharmacoepidemiol Drug Saf 1995;4:23-30.
83. Tilley BC, Barnes AB, Bergstralh E, Labarthe D, Noller KL, Colton T et al. A comparison of pregnancy history recall and medical records. Implications for retrospective studies. Am J Epidemiol 1985;121:269-81.
84. Werler MM, Pober BR, Nelson K, Holmes LB. Reporting accuracy among mothers of malformed and nonmalformed infants. Am J Epidemiol 1989;129:415-21.
85. de Jong PCM, Prevoo MLL, Zielhuis GA, Roeleveld N, Gabreels F. Accessibility and validity of data on medical drug use during pregnancy collect from various sources. J Pharmacoepidemiol 1991;2:45-57.
86. McCredie J, Kricker A, Elliott J, Forrest J. The innocent bystander. Doxylamine/dicyclomine/pyridoxine and congenital limb defects. Med J Aust 1984;140:525-7.
87. Bryant HE, Visser N, Love EJ. Records, recall loss, and recall bias in pregnancy: a comparison of interview and medical records data of pregnant and postnatal women. Am J Public Health 1989;79:78-80.
88. Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Drug Saf 2003;12:409-16.
89. Cottler LB, Robins LN. The effect of questionnaire design on reported prevalence of psychoactive medication. NIDA Res Monogr 1984;55:231-7.
90. Kimmel SE, Lewis JD, Jaskowiak J, Kishel L, Hennessy S. Enhancement of medication recall using medication pictures and lists in telephone interviews. Pharmacoepidemiol Drug Saf 2003;12:1-8.
91. Beresford SA, Coker AL. Pictorially assisted recall of past hormone use in case-control studies. Am J Epidemiol 1989;130:202-5.
92. West SL, Savitz DA, Koch G, Sheff KL, Strom BL, Guess HA et al. Demographics, health behaviors, and past drug use as predictors of recall accuracy for previous prescription medication use. J Clin Epidemiol 1997;50:975-80.
93. Zierler S, Rothman KJ. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med 1985;313:347-52.
94. Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology 2001;12:461-6.
95. Harlow SD, Linet MS. Agreement between questionnaire data and medical records. The evidence for accuracy of recall. Am J Epidemiol 1989;129:233-48.
96. Madow WG. Interview data on chronic conditions compared with information derived from medical records. Vital Health Stat 1 1967;2:1-84.
97. Watson DL. Health interview responses compared with medical records. Vital Health Stat 1 1965;46:1-74.
98. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123:894-900.
99. Tretli S, Lund-Larsen PG, Foss OP. Reliability of questionnaire information on cardiovascular disease and diabetes: cardiovascular disease study in Finnmark county. J Epidemiol Community Health 1982;36:269-73.
100. Wingo PA, Ory HW, Layde PM, Lee NC. The evaluation of the data collection process for a multicenter, population-based, case-control design. Am J Epidemiol 1988;128:206-17.
101. Linet MS, Harlow SD, McLaughlin JK, McCaffrey LD. A comparison of interview data and medical records for previous medical conditions and surgery. J Clin Epidemiol 1989;42:1207-13.
102. Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health 1989;79:1554-6.
103. Nevitt MC, Cummings SR, Browner WS, Seeley DG, Cauley JA, Vogt TM et al. The accuracy of self-report of fractures in elderly women: evidence from a prospective study. Am J Epidemiol 1992;135:490-9.
104. Wilcox AJ, Horney LF. Accuracy of spontaneous abortion recall. Am J Epidemiol 1984;120:727-33.
105. Commision on Chronic Illness. Chronic Illness in the United States, Vol. IV. Chronic Illness in a Large City: The Baltimore Study. Cambridge, MA: Harvard University Press, 1957; pp. 297-328.
106. Heliovaara M, Aromaa A, Klaukka T, Knekt P, Joukamaa M, Impivaara O. Reliability and validity of interview data on chronic diseases. The Mini-Finland Health Survey. J Clin Epidemiol 1993;46:181-91.
107. Spitz MR, Fueger JJ, Newell GR. The development of a comprehensive, institution-based patient risk evaluation program: II. Validity and reliability of questionnaire data. Am J Prev Med 1988;4:188-93.
108. Midthjell K, Holmen J, Bjorndal A, Lund-Larsen G. Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trondelag diabetes study. J Epidemiol Community Health 1992;46:537-42.
109. Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 1996;49:1407-17.
110. Bergmann MM, Calle EE, Mervis CA, Miracle-McMahill HL, Thun MJ, Heath CW. Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol 1998;147:556-62.
111. Paganini-Hill A, Chao A. Accuracy of recall of hip fracture, heart attack, and cancer: a comparison of postal survey data and medical records. Am J Epidemiol 1993;138:101-6.
112. Zhu K, McKnight B, Stergachis A, Daling JR, Levine RS. Comparison of self-report data and medical records data: results from a case-control study on prostate cancer. Int J Epidemiol 1999;28:409-17.
113. Lingard EA, Wright EA, Sledge CB. Pitfalls of using patient recall to derive preoperative status in outcome studies of total knee arthroplasty. J Bone Joint Surg Am 2001;83-A: 1149-56.
114. Mancuso CA, Charlson ME. Does recollection error threaten the validity of cross-sectional studies of effectiveness? Med Care 1995;33 (suppl 4): AS77-88.
115. Dawson EG, Kanim LE, Sra P, Dorey FJ, Goldstein TB, Delamarter RB et al. Low back pain recollection versus concurrent accounts: outcomes analysis. Spine 2002;27:984-93.
116. Linton KL, Klein BE, Klein R. The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study. Am J Epidemiol 1991;134:1438-46.
117. Rosamond WD, Sprafka JM, McGovern PG, Nelson M, Luepker RV. Validation of self-reported history of acute myocardial infarction: experience of the Minnesota Heart Survey Registry. Epidemiology 1995;6:67-9.
118. Walker MK, Whincup PH, Shaper AG, Lennon LT, Thomson AG. Validation of patient recall of doctor-diagnosed heart attack and stroke: a postal questionnaire and record review comparison. Am J Epidemiol 1998;148:355-61.
119. Naleway AL, Belongia EA, Greenlee RT, Kieke BA, Jr, Chen RT, Shay DK. Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination. Ann Intern Med 2003;139:1-7.
120. Colditz GA, Stampfer MJ, Willett WC, Stason WB, Rosner B, Hennekens CH et al. Reproducibility and validity of selfreported menopausal status in a prospective cohort study. Am J Epidemiol 1987;126:319-25.
121. Jabine TB. Reporting chronic conditions in the National Health Interview Survey. A review of findings from evaluation studies and methodological test. Vital Health Stat 2 1987;105:1-45.
122. Biering-Sorensen U. Reporting of hospitalization in the Health Interview Survey. Vital Health Stat 1 1965;61:1-71.
123. Corwin RG, Krober M, Roth HP. Patients' accuracy in reporting their past medical history, a study of 90 patients with peptic ulcer. J Chronic Dis 1971;23:875-9.
124. Udry JR, Gaughan M, Schwingl PJ, van den Berg BJ. A medical record linkage analysis of abortion underreporting. Fam Plann Perspect 1996;28:228-31.
125. Lessler JT, Harris BSH. Medicaid Data as a Source for Postmarketing Surveillance Information. Research Triangle Park, NC: Research Triangle Institute, 1984.
126. Cannell CF, Marquis KH, Laurent A. A summary of studies of interviewing methodology. Vital Health Stat 1 1977; series 2, i-viii; 1-78.
127. Bonito AJ, Farrelly MC, Han J, Lohr KN, Lubalin JS, Lux L. Assessment of the feasibility of creating a managed care encounter-level databas, RTI Project Report 6703-003, prepared for the Center for Organization and Delivery Studies, Agency for Health Care Policy and Research, Rockville, MD, 1997.
128. Stergachis AS. Record linkage studies for postmarketing drug surveillance: data quality and validity considerations. Drug Intell Clin Pharm 1988;22:157-61.
129. Rawson NS, Harding SR, Malcolm E, Lueck L. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use. J Clin Epidemiol 1998;51:1343-55.
130. Schering Laboratories. The Phantom Patient and Community Pharmacy Practice, Schering Report XVII. Kenilworth, NJ, 1996.
131. Craghead RM, Wartski DM. An evaluative study of unclaimed prescriptions. Hosp Pharm 1991;26:616-17, 632.
132. Farmer KC, Gumbhir AK. Unclaimed prescriptions: an overlooked opportunity. Am Pharm 1992; NS32:55-9.
133. Hamilton WR, Hopkins UK. Survey on unclaimed prescriptions in a community pharmacy. J Am Pharm Assoc (Wash) 1997; NS37:341-5.
134. Kirking MH, Kirking DM. Evaluation of unclaimed prescriptions in an ambulatory care pharmacy. Hosp Pharm 1993;28:90-91, 94, 102.
135. Kinnaird D, Cox T, Wilson JP. Unclaimed prescriptions in a clinic with computerized prescriber order entry. Am J Health Syst Pharm 2003;60:1468-70.
136. Psaty BM, Heckbert SR, Atkins D, Lemaitre R, Koepsell TD, Wahl PW et al. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med 1994;154:1333-9.
137. Stergachis AS. Evaluating the quality of linked automated databases for use in pharmacoepidemiology. In: Hartzema AG, Porta MS, Tilson HH, eds, Pharmacoepidemiology: An Introduction, 2nd edn. Cincinnati, OH: Harvey Whitney, 1991; pp. 222-34.
138. Harris BL, Stergachis A, Ried LD. The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization. Med Care 1990;28:907-17.
139. McKenzie DA, Semradek J, McFarland BH, Mullooly JP, McCamant LE. The validity of medicaid pharmacy claims for estimating drug use among elderly nursing home residents: the Oregon experience. J Clin Epidemiol 2000;53:1248-57.
140. Hoes AW, Grobbee DE, Lubsen J, Manin't Veld AJ, van der Does E, Hofman A. Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med 1995;123:481-7.
141. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997;50:619-25.
142. Bright RA, Avorn J, Everitt DE. Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol 1989;42:937-45.
143. Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M, Waiter SL. No causal relationship between transdermal scopolamine and seizures: methodologic lessons for pharmacoepidemiology. Clin Pharmacol Ther 1991;50:107-13.
144. Wynia MK, Cummins DS, VanGeest JB, Wilson IB. Physician manipulation of reimbursement rules for patients: between a rock and a hard place. JAMA 2000;283:1858-65.
145. Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 2003;290:2685-92.
146. Ferrara A, Quesenberry CP, Karter AJ, Njoroge CW, Jacobson AS, Selby JV. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998. Circulation 2003;107:43-8.
147. Friedman GD, Habel LA. Barbiturates and lung cancer: a re-evaluation. Int J Epidemiol 1999;28:375-9.
148. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003;290:1467-73.
149. Sidney S, Petitti DB, Soff GA, Cundiff DL, Tolan KK, Quesenberry CP, Jr. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives. Contraception 2004;70:3-10.
150. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK. Stroke in users of low-dose oral contraceptives. N Engl J Med 1996;335:8-15.
151. Sidney S, Petitti DB, Quesenberry CP, Jr, Klatsky AL, Ziel HK, Wolf S. Myocardial infarction in users of low-dose oral contraceptives. Obstet Gynecol 1996;88:939-44.
152. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659-63.
153. Quam L, Ellis LB, Venus P, Clouse J, Taylor CG, Leatherman S. Using claims data for epidemiologic research. The concordance of claims-based criteria with the medical record and patient survey for identifying a hypertensive population. Med Care 1993;31:498-507.
154. Straus SM, Bleumink GS, Dieleman JP, van der Lei J, t Jong GW, Kingma JH et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med 2004;164:1293-7.
155. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodriguez LA, Ruigomez A, Meier CR et al. Validity of the general practice research database. Pharmacotherapy 2003;23:686-9.
156. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992;1:347-9.
157. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
158. Schoonen WM, Hall AJ. Validity of the General Practice Research Database: a systematic review. Presented at the 20th International Conference on Pharmacoepidemiology and Theraupeutic Risk Management Annual Meeting, Bordeaux, France, August 22-25, 2004.
159. van Staa TP, Abenhaim L. The quality of information recorded on a UK database of primary care records: a study of hospitalizations due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 1994;3:15-21.
160. Newton KM, Wagner EH, Ramsey SD, McCulloch D, Evans R, Sandhu N et al. The use of automated data to identify complications and comorbidities of diabetes: a validation study. J Clin Epidemiol 1999;52:199-207.
161. Leveille SG, Gray S, Black DJ, LaCroix AZ, Ferrucci L, Volpato S et al. A new method for identifying antibiotictreated infections using automated pharmacy records. J Clin Epidemiol 2000;53:1069-75.
162. Friedman GD, Gerard MJ, Ury HK. Clindamycin and diarrhea. JAMA 1976;236:2498-2500.
163. Levin TR, Schmittdiel JA, Kunz K, Henning JM, Henke CJ, Colby CJ et al. Costs of acid-related disorders to a health maintenance organization. Am J Med 1997;103:520-8.
164. Sidney S, Petitti DB, Quesenberry CP, Jr. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women. Ann Intern Med 1997;127:501-8.
165. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 1999;131:927-34.
166. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001;285:2370-5.
167. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med 1995;155:1605-9.
168. Donahue JG, Weiss ST, Goetsch MA, Livingston JM, Greineder DK, Platt R. Assessment of asthma using automated and full-text medical records. J Asthma 1997;34:273-81.
169. Andrade SE, Gurwitz JH, Chan KA, Donahue JG, Beck A, Boles M et al. Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol 2002;55:310-13.
170. Donahue JG, Chan KA, Andrade SE, Beck A, Boles M, Buist DS etal. Gastric and duodenal safety of daily alendronate. Arch Intern Med 2002;162:936-42.
171. Bohlke K, Davis RL, Marcy SM, Braun MM, DeStefano F, Black SB et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003;112:815-20.
172. Chan KA, Truman A, Gurwitz JH, Hurley JS, Martinson B, Platt R et al. A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med 2003;163:728-34.
173. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
174. Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder ES, Shaw M et al. A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. Arch Dermatol 1991;127:831-8.
175. Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M. Descriptive epidemiology of agranulocytosis. Arch Intern Med 1992;152:1475-80.
176. Staffa JA, Jones JK, Gable CB, Verspeelt JP, Amery WK. Risk of selected serious cardiac events among new users of antihistamines. Clin Ther 1995;17:1062-77.
177. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996;60:8-13.
178. Steinwachs DM, Stuart ME, Scholle S, Starfield B, Fox MH, Weiner JP. A comparison of ambulatory Medicaid claims to medical records: a reliability assessment. Am J Med Qual 1998;13:63-9.
179. Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 2000;151:488-96.
180. Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001;58:1161-7.
181. Wang PS, Walker AM, Tsuang MT, Orav EJ, Levin R, Avorn J. Finding incident breast cancer cases through US claims data and a state cancer registry. Cancer Causes Control 2001;12:257-65.
182. Ngo DL, Marshall LM, Howard RN, Woodward JA, Southwick K, Hedberg K. Agreement between self-reported information and medical claims data on diagnosed diabetes in Oregon's Medicaid population. J Public Health Manag Pract 2003;9:542-4.
183. Rogers SO, Ray WA, Smalley WE. A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States). Cancer Causes Control 2004;15:193-9.
184. Rawson NS, Malcolm E. Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat Med 1995;14:2627-43.
185. Edouard L, Rawson NS. Reliability of the recording of hysterectomy in the Saskatchewan health care system. Br J Obstet Gynaecol 1996;103:891-7.
186. Rawson NS, Malcolm E, D'Arcy C. Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol 1997;32:191-9.
187. Walker AM, Szneke P, Weatherby LB, Dicker LW, Lanza LL, Loughlin JE et al. The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada. Am J Med 1999;107:356-62.
188. West SL, Richter A, Melfi CA, McNutt M, Nennstiel ME, Mauskopf JA. Assessing the Saskatchewan database for outcomes research studies of depression and its treatment. J Clin Epidemiol 2000;53:823-31.
189. van der Klauw MM, Stricker BH, Herings RM, Cost WS, Valkenburg HA, Wilson JH. A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 1993;35:400-8.
190. Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998;158:1108-12.
191. van der Klauw MM, Goudsmit R, Halie MR, van't Veer MB, Herings RM, Wilson JH et al. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med 1999;159:369-74.
192. Movig KL, Leufkens HG, Lenderink AW, Egberts AC. Validity of hospital discharge International Classification of Diseases (ICD) codes for identifying patients with hyponatremia. J Clin Epidemiol 2003;56:530-5.
193. Dornan S, Murray FE, White G, McGilchrist MM, Evans JM, McDevitt DG et al. An audit of the accuracy of upper gastrointestinal diagnoses in Scottish Morbidity Record 1 data in Tayside. Health Bull (Edinb) 1995;53:274-9.
194. Evans JM, McMahon AD, McGilchrist MM, White G, Murray FE, McDevitt DG et al. Topical non-steroidal antiinflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ 1995;311:22-6.
195. Evans JM, Macgregor AM, Murray FE, Vaidya K, Morris AD, MacDonald TM. No association between non-steroidal anti-inflammatory drugs and acute appendicitis in a case-control study. Br J Surg 1997;84:372-4.
196. Evans JM, McMahon AD, Murray FE, McDevitt DG, MacDonald TM. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 1997;40:619-22.
197. Morris AD, Boyle DI, MacAlpine R, Emslie-Smith A, Jung RT, Newton RW et al. The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. DARTS/MEMO Collaboration. BMJ 1997;315:524-8.
198. McMahon AD, Evans JM, MacDonald TM. Hypersensitivity reactions associated with exposure to naproxen and ibuprofen: a cohort study. J Clin Epidemiol 2001;54:1271-4.
199. Struthers AD, Donnan PT, Lindsay P, McNaughton D, Broomhall J, MacDonald TM. Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study. Heart 2002;87:229-34.
200. Steinke DT, Weston TL, Morris AD, MacDonald TM, Dillon JF. The epidemiology of liver disease in Tayside database: a population-based record-linkage study. J Biomed Inform 2002;35:186-93.
201. Meier CR, Sturkenboom MC, Cohen AS, Jick H. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol 1998;25:1515-19.
202. Derby L, Maier WC. Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol 2000;105:912-16.
203. Lawrenson R, Todd JC, Leydon GM, Williams TJ, Farmer RD. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol 2000;49:591-6.
204. García-Rodríguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 2001;12:88-93.
205. Seshadri S, Zornberg GL, Derby LE, Myers MW, Jick H, Drachman DA. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch Neurol 2001;58:435-40.
206. Soriano JB, Maier WC, Visick G, Pride NB. Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database. Eur J Epidemiol 2001;17:1075-80.
207. Huerta C, Zhao SZ, Garcia Rodriguez LA. Risk of acute liver injury in patients with diabetes. Pharmacotherapy 2002;22:1091-6.
208. Lewis JD, Brensinger C, Bilker WB, Strom BL. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf 2002;11:211-18.
209. Margolis DJ, Bilker W, Knauss J, Baumgarten M, Strom BL. The incidence and prevalence of pressure ulcers among elderly patients in general medical practice. Ann Epidemiol 2002;12:321-5.
210. Ruigómez A, Johansson S, Wallander MA, Rodriguez LA. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 2002;55:358-63.
211. van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C. Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 2002;17:465-71.
212. Watson DJ, Rhodes T, Cai B, Guess HA. Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis. Arch Intern Med 2002;162:1105-10.
213. Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch Dermatol 2003;139:1425-9.
214. Huerta C, Garcia Rodriguez LA, Wallander MA, Johansson S. Users of oral steroids are at a reduced risk of developing irritable bowel syndrome. Pharmacoepidemiol Drug Saf 2003;12:583-8.
215. Ruigómez A, Garcia Rodriguez LA, Johansson S, Wallander MA. Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome? Maturitas 2003;44:133-40.
216. Yang CC, Jick SS, Jick H. Lipid-lowering drugs and the risk of depression and suicidal behavior. Arch Intern Med 2003;163:1926-32.
217. Ronquist G, Rodriguez LA, Ruigomez A, Johansson S, Wallander MA, Frithz G et al. Association between captopril, other antihypertensive drugs and risk of prostate cancer. Prostate 2004;58:50-6.
218. Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med 2004;164:317-19.
219. Strom BL, Carson JL, Morse ML, LeRoy AA. The computerized on-line Medicaid pharmaceutical analysis and surveillance system: a new resource for postmarketing drug surveillance. Clin Pharmacol Ther 1985;38:359-64.
220. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol 1989;129:837-49.
221. Shapiro S. The role of automated record linkage in the postmarketing surveillance of drug safety: a critique. Clin Pharmacol Ther 1989;46:371-86.
222. Iezzoni LI, Burnside S, Sickles L, Moskowitz MA, Sawitz E, Levine PA. Coding of acute myocardial infarction. Clinical and policy implications. Ann Intern Med 1988;109:745-51.
223. Pladevall M, Goff DC, Nichaman MZ, Chan F, Ramsey D, Ortiz C et al. An assessment of the validity of ICD Code 410 to identify hospital admissions for myocardial infarction: The Corpus Christi Heart Project. Int J Epidemiol 1996;25:948-52.
224. Department of Health and Human Services. Protection of Human Subjects, Title 45 Part 46: Revised. Code of Federal Regulations, 1991.
225. Linet MS. Testimony on impact of HIPAA on research, American College of Epidemiology, 2003.
226. Lydon-Rochelle M, Holt VL. HIPAA transition: challenges of a multisite medical records validation study of maternally linked birth records. Matern Child Health J 2004;8:35-8.